PubMed Abstract | CrossRef Full Text | Google Scholar
31. Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat Protoc (2013) 8(1):162–75. doi:10.1038/nprot.2012.150 operating principle of circuit breaker
CrossRef Full Text | Google Scholar
32. Wilson HK, Canfield SG, Hjortness MK, Palecek SP, Shusta EV. Exploring the effects of cell seeding density on the differentiation of human pluripotent stem cells to brain microvascular endothelial cells. Fluids Barriers CNS (2015) 12:13. doi:10.1186/s12987-015-0007-9
PubMed Abstract | CrossRef Full Text | Google Scholar
33. Tohyama S, Fujita J, Fujita C, Yamaguchi M, Kanaami S, Ohno R, et al. Efficient large-scale 2D culture system for human induced pluripotent stem cells and differentiated cardiomyocytes. Stem Cell Rep (2017) 9(5):1406–14. doi:10.1016/j.stemcr.2017.08.025
PubMed Abstract | CrossRef Full Text | Google Scholar
34. Kirkeby A, Grealish S, Wolf DA, Nelander J, Wood J, Lundblad M, et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep (2012) 1(6):703–14. doi:10.1016/j.celrep.2012.04.009
PubMed Abstract | CrossRef Full Text | Google Scholar
35. Nicoleau C, Varela C, Bonnefond C, Maury Y, Bugi A, Aubry L, et al. Embryonic stem cells neural differentiation qualifies the role of Wnt/beta-Catenin signals in human telencephalic specification and regionalization. Stem Cells (2013) 31(9):1763–74. doi:10.1002/stem.1462
CrossRef Full Text | Google Scholar
36. Swistowski A, Peng J, Liu Q, Mali P, Rao MS, Cheng L, et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells (2010) 28(10):1893–904. doi:10.1002/stem.499
PubMed Abstract | CrossRef Full Text | Google Scholar
37. Momcilovic O, Liu Q, Swistowski A, Russo-Tait T, Zhao Y, Rao MS, et al. Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells. Stem Cells Dev (2014) 23(4):406–20. doi:10.1089/scd.2013.0412
PubMed Abstract | CrossRef Full Text | Google Scholar
38. Efthymiou AG, Steiner J, Pavan WJ, Wincovitch S, Larson DM, Porter FD, et al. Rescue of an in vitro neuron phenotype identified in Niemann-Pick disease, type C1 induced pluripotent stem cell-derived neurons by modulating the WNT pathway and calcium signaling. Stem Cells Transl Med (2015) 4(3):230–8. doi:10.5966/sctm.2014-0127
PubMed Abstract | CrossRef Full Text | Google Scholar
39. Shaltouki A, Sivapatham R, Pei Y, Gerencser AA, Momcilovic O, Rao MS, et al. Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines. Stem Cell Reports (2015) 4(5):847–59. doi:10.1016/j.stemcr.2015.02.019
PubMed Abstract | CrossRef Full Text | Google Scholar
40. Momcilovic O, Sivapatham R, Oron TR, Meyer M, Mooney S, Rao MS, et al. Derivation, characterization, and neural differentiation of integration-free induced pluripotent stem cell lines from Parkinson’s disease patients carrying SNCA, LRRK2, PARK2, and GBA mutations. PLoS One (2016) 11(5):e0154890. doi:10.1371/journal.pone.0154890
PubMed Abstract | CrossRef Full Text | Google Scholar
41. Pei Y, Peng J, Behl M, Sipes NS, Shockley KR, Rao MS, et al. Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes. Brain Res (2016) 1638(Pt A):57–73. doi:10.1016/j.brainres.2015.07.048
PubMed Abstract | CrossRef Full Text | Google Scholar
42. Peng J, Liu Q, Rao MS, Zeng X. Survival and engraftment of dopaminergic neurons manufactured by a good manufacturing practice-compatible process. Cytotherapy (2014) 16(9):1305–12. doi:10.1016/j.jcyt.2014.06.002
PubMed Abstract | CrossRef Full Text | Google Scholar
43. Ahmadian Baghbaderani B, Tian X, Scotty Cadet J, Shah K, Walde A, Tran H, et al. A newly defined and xeno-free culture medium supports every-other-day medium replacement in the generation and long-term cultivation of human pluripotent stem cells. PLoS One (2016) 11(9):e0161229. doi:10.1371/journal.pone.0161229
PubMed Abstract | CrossRef Full Text | Google Scholar
44. Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell (2011) 9(1):17–23. doi:10.1016/j.stem.2011.06.007
PubMed Abstract | CrossRef Full Text | Google Scholar
45. Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol (2011) 29(12):1117–9. doi:10.1038/nbt.2052
PubMed Abstract | CrossRef Full Text | Google Scholar
46. Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol (2011) 13(5):541–9. doi:10.1038/ncb2239
PubMed Abstract | CrossRef Full Text | Google Scholar
47. Lohle M, Hermann A, Glass H, Kempe A, Schwarz SC, Kim JB, et al. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells (2012) 30(3):570–9. doi:10.1002/stem.1016
PubMed Abstract | CrossRef Full Text | Google Scholar
48. Hu S, Zhao MT, Jahanbani F, Shao NY, Lee WH, Chen H, et al. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells. JCI Insight (2016) 1(8):e85558. doi:10.1172/jci.insight.85558
PubMed Abstract | CrossRef Full Text | Google Scholar
49. Lee JH, Laronde S, Collins TJ, Shapovalova Z, Tanasijevic B, McNicol JD, et al. Lineage-specific differentiation is influenced by state of human pluripotency. Cell Rep (2017) 19(1):20–35. doi:10.1016/j.celrep.2017.03.036
PubMed Abstract | CrossRef Full Text | Google Scholar
50. Sanchez-Freire V, Lee AS, Hu S, Abilez OJ, Liang P, Lan F, et al. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. J Am Coll Cardiol (2014) 64(5):436–48. doi:10.1016/j.jacc.2014.04.056
PubMed Abstract | CrossRef Full Text | Google Scholar
51. Koehler KR, Tropel P, Theile JW, Kondo T, Cummins TR, Viville S, et al. Extended passaging increases the efficiency of neural differentiation from induced pluripotent stem cells. BMC Neurosci (2011) 12:82. doi:10.1186/1471-2202-12-82
PubMed Abstract | CrossRef Full Text | Google Scholar
Keywords: current good manufacturing practices, induced pluripotent stem cells, differentiation, cell therapy, regenerative medicine
Citation: Shafa M, Yang F, Fellner T, Rao MS and Baghbaderani BA (2018) Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers. Front. Med. 5:69. doi: 10.3389/fmed.2018.00069
Received: 29 November 2017; Accepted: 28 February 2018; Published: 15 March 2018
Copyright: © 2018 Shafa, Yang, Fellner, Rao and Baghbaderani. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Behnam Ahmadian Baghbaderani, YmVobmFtLmFobWFkaWFuYmFnaGJhZGVyYW5pJiN4MDAwNDA7bG9uemEuY29t
mccb circuit breaker definition Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.